Core Viewpoint - The company announced a capital increase agreement with Qiteng Robotics, involving an investment of 130 million RMB, but the investment has not yet been executed and carries risks of non-completion [1][2][3]. Group 1: Investment Agreement Details - The company’s second shareholder, Mr. Li Qifu, signed an investment agreement to subscribe to an increase in registered capital of Qiteng Robotics amounting to 19.71521 million RMB [1]. - As of the announcement date, Mr. Li has not paid the investment amount, and the investment has not been approved by Qiteng Robotics' board or shareholders, indicating a risk of non-completion [2]. - The business cooperation between Mr. Li and Qiteng Robotics is still in the preliminary stage, with no specific cooperation plan agreed upon [2]. Group 2: Business Impact - The main business of Qiteng Robotics is unrelated to the company’s current operations, which focus on automotive sealing strips and components [3]. - The expected impact on the company’s performance for 2025 is minimal due to the lack of substantial business cooperation with Qiteng Robotics [3]. Group 3: Correction of Information - A correction was made regarding the legal representative of Qiteng Robotics, changing from "Zhu Dong" to "Zhu Dong" [4].

更正公告 证券代码：301087 证券简称：可孚医疗 公告编号：2023-038 可孚医疗科技股份有限公司 关于《首次公开发行股票并在创业板上市之上市公告书》的 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 可孚医疗科技股份有限公司（以下简称"公司"或"可孚医疗"）于 2021 年 10 月 22 日披露了《可孚医疗科技股份有限公司首次公开发行股票并在创业板 上市之上市公告书》（以下简称"《上市公告书》"），因工作人员疏忽，《上 市公告书》第二节之"二、股票上市相关信息"中，股东张志明先生持有的公司 首次公开发行前已发行股份可上市交易日期表述有误，现就有关内容进行更正， 具体情况如下： 一、张志明先生股份锁定的披露情况 公司在《首次公开发行股票并在创业板上市招股说明书》（以下简称"《招 股说明书》"）及《上市公告书》中披露的张志明先生股份锁定承诺情况如下： | 序号 | 文件名称 | 具体章节 | 承诺内容 | | --- | --- | --- | --- | | 1 | 《招股说 明书》 | 担任本公司董事、监事、高 级管理人员的股东关于股 | 担任本公 ...